Меди-Маа

Меди-Маа (Macrosalb 99mTc) is a radiopharmaceutical used in nuclear medicine for diagnostic imaging procedures. This sterile, injectable agent helps visualize blood flow and detect abnormalities in the lungs and other organs. Short half-life ensures minimal radiation exposure.

Macrosalb 99mTc is primarily used in nuclear medicine imaging to assess pulmonary perfusion and detect conditions like pulmonary embolism. It may also assist in evaluating blood flow in other organs, such as the brain or kidneys. This diagnostic tool supports physicians in identifying vascular abnormalities without invasive procedures.

After intravenous administration, Macrosalb 99mTc distributes through the bloodstream, highlighting areas with normal blood flow. The radioactive tracer emits gamma rays, which are detected by a gamma camera to create detailed images. Patients typically experience no immediate effects beyond the imaging process itself.

As a radiopharmaceutical, Macrosalb 99mTc should only be handled and administered by trained medical professionals in controlled settings. Pregnant or breastfeeding individuals should inform their healthcare provider before use due to potential radiation exposure. Patients must follow facility-specific safety protocols during and after administration.

No known drug interactions exist with Macrosalb 99mTc, as it is a diagnostic agent rather than a therapeutic drug. However, other radiopharmaceuticals or recent nuclear medicine studies may affect imaging results. Patients should disclose all medications and recent medical procedures to their healthcare provider.